Showing 1 - 7 results of 7 for search 'Xiaoyan Kang', query time: 0.01s
Refine Results
-
1
-
2
-
3
-
4
-
5
Innovative Solutions for Multidrug-Resistant Organisms’ Infections in Intensive Care Unit: A Joint Efficacy Evaluation of Multidisciplinary Team and SHEL (Software, Hardware, Envir... by Xiaoyan Kang, MD, Ping Zhang, DNP, Qing Xu, MD, Zhengqun Feng, MD, Bei Yin, MD
Published 2025-01-01Get full text
Article -
6
Iparomlimab and tuvonralimab (QL1706) plus chemotherapy and bevacizumab for EGFR-mutant patients with advanced non-small cell lung cancer after failure of EGFR-tyrosine kinase inhi... by Yaxiong Zhang, Yan Huang, Yunpeng Yang, Yuanyuan Zhao, Hongyun Zhao, Ningning Zhou, Likun Chen, Ting Zhou, Gang Chen, Shen Zhao, Huaqiang Zhou, Hui Li, Xiaoyan Kang, Li Zhang, Wenfeng Fang
Published 2025-07-01Get full text
Article -
7
The low-dose CHK1 inhibitor prexasertib triggers VDAC1 dephosphorylation to activate mtDNA-STING signaling and synergize immunotherapy by Yu Fu, Xiaoyan Kang, Wenting Li, Zanhong Wang, Wanwan Luo, Bin Yang, Yaoyuan Cui, Funian Lu, Tianyu Qin, Xingyuan Hu, Jingjing Yin, Xi Li, Junpeng Fan, Beibei Wang, Gang Chen, Rourou Xiao, Zhiqiang Han, Ensong Guo, Xu Qin
Published 2025-05-01Get full text
Article